Max Robotics — Global Service Robot Directory + US Certification

About

Jalal B. Jalaly is a head and neck pathologist whose research centers on the intersection of human papillomavirus (HPV)-related oropharyngeal cancers and precision surgical oncology. His most cited work, a 2022 benchmark study on oncologic outcomes after transoral robotic resection, established a novel model for predicting lethal recurrence risk in HPV-positive patients. By integrating histopathologic features with clinical data, Jalaly’s model helps stratify patients who may benefit from de-escalated or intensified adjuvant therapy—a critical advance in reducing overtreatment while improving survival. With 16 citations in just two years, this paper has rapidly influenced surgical pathology guidelines and sparked further investigation into risk-adapted management. Beyond this landmark study, Jalaly’s broader contributions include refining diagnostic criteria for HPV-driven oropharyngeal cancers and characterizing tumor microenvironment biomarkers. His work bridges the gap between surgical pathology and clinical decision-making, offering tangible tools for oncologists navigating the rising incidence of HPV-related head and neck cancers. For students and researchers, Jalaly exemplifies how targeted, clinically anchored research can directly reshape treatment paradigms and improve patient outcomes.